drugset / Trial / NCT00627445
Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. The trial aims to investigate if the blood glucose control of biphasic insulin aspart 50 is at least as effective as treatment with biphasic insulin aspart 30 both in combination with metformin.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | biphasic insulin aspart 30 | Protein / enzyme biologic | — | Subcutaneous |
| Subject | biphasic insulin aspart 50 | Unknown | — | Subcutaneous |
| Background | Metformin | Small molecule | 500 mg | Oral |
| Background | Metformin | Small molecule | 2000 mg | Oral |